A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study
Susan M. Blaney*, Michael Tagen, Arzu Onar-Thomas, Stacey L. Berg, Sri Gururangan, Kathleen Scorsone, Jack Su, Stewart Goldman, Mark W. Kieran, Larry Kun, Jim Boyett, Clinton Stewart
Dive into the research topics of 'A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study'. Together they form a unique fingerprint.